261 related articles for article (PubMed ID: 35283391)
1. Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil.
Tanaka S; Kawaguchi T; Kudo R; Kimura M; Rikitake Y; Iwao C; Rikitake M; Iwao K; Aizawa A; Kariya Y; Matsuda M; Miyauchi S; Takajo I; Umekita K
Intern Med; 2022 Oct; 61(20):3131-3135. PubMed ID: 35283391
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil in neuropsychiatric systemic lupus erythematosus.
Jose J; Paulose BK; Vasuki Z; Danda D
Indian J Med Sci; 2005 Aug; 59(8):353-6. PubMed ID: 16129929
[TBL] [Abstract][Full Text] [Related]
3. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of Lupus Cerebrovascular Disease with Mycophenolate Mofetil.
Higashioka K; Yoshida K; Oryoji K; Kamada K; Mizuki S; Tsukamoto H; Yokota E; Akashi K
Intern Med; 2015; 54(17):2255-9. PubMed ID: 26328657
[TBL] [Abstract][Full Text] [Related]
5. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
Sixdorf U; Bauer H; Märker-Hermann E
Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
Weng MY; Weng CT; Liu MF
Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
Kazderova M; Jancova E; Rysava R; Merta M; Tesar V
Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
Mak A; Mok CC
Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive treatment for proliferative lupus nephritis.
Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
[TBL] [Abstract][Full Text] [Related]
11. Treatment for lupus nephritis.
Henderson L; Masson P; Craig JC; Flanc RS; Roberts MA; Strippoli GF; Webster AC
Cochrane Database Syst Rev; 2012 Dec; 12():CD002922. PubMed ID: 23235592
[TBL] [Abstract][Full Text] [Related]
12. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
Dittrich K; Ross S; Benz K; Amann K; Dötsch J
Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus complicated with pulmonary hemorrhage in a 17-year-old female.
Vijatov-Djuric G; Stojanovic V; Tomic J; Konstantinidis N; Konstantinidis G
Lupus; 2010 Nov; 19(13):1561-4. PubMed ID: 20682580
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much?
Beimler JH; Andrassy K
Pediatr Nephrol; 2004 Sep; 19(9):949-55. PubMed ID: 15257454
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological therapy of lupus nephritis.
Fine DM
JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.
Fu YF; Liu GL
Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide-induced seizures in a patient with neuropsychiatric systemic lupus erythematosus (NPSLE): A case report.
Zhang L; Shi Y; Zhang J; Wu J; Jiang W
Front Immunol; 2023; 14():1122629. PubMed ID: 36999036
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy.
Nawata T; Kubo M; Fujii S; Shiragami K; Ikegami T; Kobayashi S; Hisano S; Yano M
Intern Med; 2018 Jul; 57(14):2067-2070. PubMed ID: 29491296
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.
Glicklich D; Acharya A
Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
